Tersolisib (STX-478): Mechanism of Action

Tersolisib (STX-478) MOA：Targeting PI3Kα/PI3K-AKT-mTOR Pathway for Breast Cancer

🎯 check Tersolisib (STX-478) product page

Tersolisib is a mutant-specific PI3Kα inhibitor. It affects PI3K/AKT/mTOR signaling by allosteric binding, inhibiting cancer.

Primary Applications and Mechanism of Action

Jump to: